Trial intelligence / Profile preview

Methylprednisolone on glucose homeostasis in hip and knee arthroplasty

NCT02332603Phase 3Completed

Sponsor
Rigshospitalet
Start
Jan 2015
Primary completion
Jan 2017
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection in osteoarthritis (OA), sponsored by Rigshospitalet. Started Jan 2015; status: completed.

02

Drugs

methylprednisolone injection
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02332603.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02332603.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call